{"id":13601,"date":"2023-05-25T09:01:06","date_gmt":"2023-05-25T13:01:06","guid":{"rendered":"https:\/\/ifintechworld.com\/markets\/is-illumina-stock-a-better-pick-over-tmo\/"},"modified":"2023-05-25T09:01:07","modified_gmt":"2023-05-25T13:01:07","slug":"is-illumina-stock-a-better-pick-over-tmo","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=13601","title":{"rendered":"Is Illumina Stock A Better Pick Over TMO?"},"content":{"rendered":"<div>\n<p>We believe <strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/ILMN\/\">Illumina stock<\/strong> (NASDAQ<fbs-ticker data-name=\"NDAQ\" data-href=\"https:\/\/www.forbes.com\/companies\/nasdaq\" data-type=\"stock\"><br \/>\n  NDAQ<br \/>\n <\/fbs-ticker>: ILMN) and its industry peer <strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/TMO\/\">Thermo Fisher Scientific stock<\/strong> (NYSE: TMO) are good buying opportunities and will likely offer similar returns in the next three years. ILMN trades at a higher valuation of <strong>7.3x<\/strong> trailing revenues, compared to <strong>4.6x<\/strong> for TMO, partly due to its financial position. However, Thermo Fisher Scientific<fbs-ticker data-name=\"TMO\" data-href=\"https:\/\/www.forbes.com\/companies\/thermo-fisher-scientific\" data-type=\"stock\"><br \/>\n  TMO<br \/>\n <\/fbs-ticker> has seen better revenue growth in recent years and is more profitable, as discussed below.<\/p>\n<p>Looking at stock returns, ILMN has fared slightly better with 1% returns this year vs. -5% returns for TMO. However, both have underperformed the broader S&amp;P500 index, up 8%. There is more to the comparison, and in the sections below, we discuss why we believe that both ILMN and TMO stock will offer good returns in the next three years. We compare a slew of factors, such as historical revenue growth, returns, and valuation, in an interactive dashboard analysis of <strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/ILMN\/no-login-required\/8Smz84Dq\/Illumina-vs-Thermo-Fisher-Scientific-With-Return-Forecast-Of-31-36-Both-Seem-Like-Good-Bets?fromforbesandarticle=trefis230525\">Illumina vs. Thermo Fisher Scientific<\/strong>: <strong>Which Stock Is A Better Bet?<\/strong> Parts of the analysis are summarized below.<\/p>\n<p><strong>1. Thermo Fisher Scientific\u2019s Revenue Growth Is Better <\/strong><\/p>\n<ul>\n<li>Thermo Fisher Scientific\u2019s revenue growth has been much better, with a <strong>20.8%<\/strong> average annual growth rate in the last three years, compared to <strong>10.8%<\/strong> for Illumina.<\/li>\n<li>Illumina\u2019s sales have been rising due to the booming demand for gene sequencing. The company\u2019s cancer screening and population genomics testing are driving its revenue growth. Also, gains from Covid-19 surveillance programs have contributed to the top-line expansion.<\/li>\n<li>Illumina has a recurring revenue model from consumables and services, accounting for 84% of the company\u2019s total sales in 2022.<\/li>\n<li>Thermo Fisher Scientific manufactures analytical laboratory instruments used in various tests, and the pandemic has increased demand for these instruments. Its sales growth is buoyed by continued market share gains for its instruments.<\/li>\n<li>Thermo Fisher Scientific has seen a good 15% growth in 2022, primarily driven by its Laboratory Products &amp; Biopharma Services segment, which saw a substantial 51% y-o-y growth. This can be attributed to its December 2021 acquisition of PPD<fbs-ticker data-name=\"PPD\" data-href=\"https:\/\/www.forbes.com\/companies\/ppd\" data-type=\"stock\"><br \/>\n   PPD<br \/>\n  <\/fbs-ticker> Inc. \u2013 a clinical research services provider to the biopharma and biotech industry \u2013 for $17.4 billion. The PPD business contributed $7.1 billion to the company\u2019s top line in 2022.<\/li>\n<li>Our <strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/ILMN\/no-login-required\/qGB80Bd7\/Illumina-ILMN-Revenue-Comparison?fromforbesandarticle=trefis230525\">Illumina Revenue Comparison<\/strong> and <strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/TMO\/no-login-required\/drTLdgUn\/Thermo-Fisher-Scientific-TMO-Revenue-Comparison?fromforbesandarticle=trefis230525\">Thermo Fisher Scientific Revenue Comparison<\/strong> dashboards provide more insight into the companies\u2019 sales.<\/li>\n<li>Looking forward, Thermo Fisher Scientific\u2019s revenue is expected to grow marginally faster than Illumina\u2019s over the next three years. The table below summarizes our revenue expectations for the two companies over the next three years. It points to a CAGR of 9.4% for Illumina, compared to a 10.6% CAGR for Thermo Fisher Scientific, based on Trefis Machine Learning analysis.<\/li>\n<li>Note that we have different methodologies for companies negatively impacted by Covid and those not impacted or positively impacted by Covid while forecasting future revenues. For companies negatively affected by Covid, we consider the quarterly revenue recovery trajectory to predict recovery to the pre-Covid revenue run rate. Beyond the recovery point, we apply the average annual growth observed three years before Covid to simulate a return to normal conditions. For companies registering positive revenue growth during Covid, we consider yearly average growth before Covid with a certain weight to growth during Covid and the last twelve months.<\/li>\n<\/ul>\n<p><fbs-ad position=\"inread\" progressive=\"\" ad-id=\"article-0-inread\" aria-hidden=\"true\" role=\"presentation\"><\/fbs-ad><\/p>\n<p><strong>Thermo Fisher Scientific Is More Profitable But Comes With Higher Risk<\/strong><\/p>\n<ul>\n<li>Illumina\u2019s operating margin has slid from <strong>29.3%<\/strong> in 2019 to <strong>-90.6%<\/strong> in 2022, while Thermo Fisher Scientific\u2019s operating margin declined marginally from <strong>20.6%<\/strong> to <strong>20.3%<\/strong> over this period.<\/li>\n<li>Looking at the last twelve-month period, Thermo Fisher Scientific\u2019s operating margin of <strong>18.3% <\/strong>fares much better than<strong> -99.3% <\/strong>for Illumina.<\/li>\n<li>This sharp decline for Illumina can be attributed to an impairment charge of $3.9 billion on goodwill and a legal contingency of $458 million in potential fines from the European Commission related to the Grail acquisition.<\/li>\n<li>Note that Illumina acquired Grail in 2021 despite regulatory concerns, and it is likely to face a fine of 10% of its global annual turnover as a penalty for closing the deal without EU antitrust approval.<sup> [<\/sup><sup data-ga-track=\"ExternalLink:https:\/\/www.reuters.com\/markets\/deals\/illumina-face-eu-fine-10-turnover-over-grail-deal-sources-2023-01-11\/\">1<\/sup><sup>]<\/sup><\/li>\n<li>Our <strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/ILMN\/no-login-required\/B4gBMGYs\/Illumina-ILMN-Operating-Income-Comparison?fromforbesandarticle=trefis230525\">Illumina Operating Income Comparison<\/strong><strong> <\/strong>and <strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/TMO\/no-login-required\/BcSuhsLT\/Thermo-Fisher-Scientific-TMO-Operating-Income-Comparison?fromforbesandarticle=trefis230525\">Thermo Fisher Scientific Operating Income Comparison<\/strong> dashboards have more details.<\/li>\n<li>Thermo Fisher Scientific\u2019s free cash flow margin of <strong>17.5%<\/strong> is higher than <strong>5.2%<\/strong> for Illumina.<\/li>\n<li>Looking at financial risk, Illumina fares better with its <strong>6.9%<\/strong> debt as a percentage of equity lower than <strong>17.4%<\/strong> for Thermo Fisher Scientific and its <strong>12.9%<\/strong> cash as a percentage of assets higher than <strong>3.7% <\/strong>for the latter, implying that Illumina has a better debt position and more cash cushion.<\/li>\n<\/ul>\n<p><strong>3. The Net of It All<\/strong><\/p>\n<ul>\n<li>We see that Thermo Fisher Scientific has demonstrated better revenue growth, is more profitable, and is available at a comparatively lower valuation multiple. On the other hand, Illumina has a better debt position and cash cushion.<\/li>\n<li>Now, looking at prospects, using P\/S as a base, due to high fluctuations in P\/E and P\/EBIT, we believe Thermo Fisher Scientific is the better choice of the two, given its lower valuation and better prospects. That said, even Illumina stock is expected to give similar returns.<\/li>\n<li>If we compare the current valuation multiples to the historical averages, Illumina fares better, with its stock currently trading at <strong>7.1x<\/strong> trailing revenues vs. the last five-year average of <strong>15.0x. <\/strong>In contrast, Thermo Fisher Scientific stock trades at <strong>4.6x<\/strong> trailing revenues vs. the last five-year average of <strong>5.9x<\/strong>.<\/li>\n<li>Our <strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/ILMN\/no-login-required\/Nms4gBrS\/Illumina-ILMN-Valuation-Ratios-Comparison?fromforbesandarticle=trefis230525\">Illumina Valuation Ratios Comparison<\/strong> and <strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/TMO\/no-login-required\/V3bdKCMS\/Thermo-Fisher-Scientific-TMO-Valuation-Ratios-Comparison?fromforbesandarticle=trefis230525\">Thermo Fisher Scientific Valuation Ratios Comparison<\/strong> have more details.<\/li>\n<li>The table below summarizes our revenue and return expectations for Illumina and Thermo Fisher Scientific over the next three years and points to an expected return of <strong>31%<\/strong> for ILMN over this period vs. a <strong>36%<\/strong> expected return for TMO, based on Trefis Machine Learning analysis \u2013 <strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/ILMN\/no-login-required\/8Smz84Dq\/Illumina-vs-Thermo-Fisher-Scientific-With-Return-Forecast-Of-31-36-Both-Seem-Like-Good-Bets?fromforbesandarticle=trefis230525\">Illumina vs. Thermo Fisher Scientific<\/strong> \u2013 which also provides more details on how we arrive at these numbers.<\/li>\n<\/ul>\n<p>While ILMN and TMO may offer good returns in the next three years, the Covid-19 crisis has created many pricing discontinuities, which can offer attractive trading opportunities. For example, you\u2019ll be surprised at how counter-intuitive the stock valuation is for<strong> <\/strong><strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/ABT\/no-login-required\/cnpzyIxg\/Abbott-Laboratories-vs-Amerco-ABT-stock-s-significantly-higher-valuation-vs-UHAL-appears-counterintuitive?fromforbesandarticle=trefis230525\">Abbott vs. Amerco<\/strong><strong>.<\/strong><\/p>\n<p>What if you\u2019re looking for a high-performance portfolio with a low downside instead? Here\u2019s a <strong data-ga-track=\"ExternalLink:https:\/\/www.trefis.com\/data\/companies\/PORTFOLIOS\/no-login-required\/BPo8U0Xc\/Reinforced-Value-Portfolio-with-439-Return-Since-2016-vs-87-for-S-P-500?fromforbesandarticle=trefis230525\">reinforced value portfolio<\/strong> that has beaten the market consistently while limiting losses during periods of sharp market declines.<\/p>\n<ol>\n<li>Exclusive: Illumina to face EU fine of 10% of turnover over Grail deal -sources, Foo Yun Chee, Reuters, Jan 12, 2023 [\u21a9]<\/li>\n<\/ol>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.forbes.com\/sites\/greatspeculations\/2023\/05\/25\/is-illumina-stock-a-better-pick-over-tmo\/\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>We believe Illumina stock (NASDAQ NDAQ : ILMN) and its industry peer Thermo Fisher Scientific stock (NYSE: TMO) are good buying opportunities and will likely offer similar returns in the next three years. ILMN trades at a higher valuation of 7.3x trailing revenues, compared to 4.6x for TMO, partly due to its financial position. However, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":13602,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[241],"tags":[83],"class_list":["post-13601","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-markets","tag-featured"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Is Illumina Stock A Better Pick Over TMO? | iFintechWorld<\/title>\n<meta name=\"description\" content=\"We believe Illumina stock (NASDAQ NDAQ : ILMN) and its industry peer Thermo Fisher Scientific stock (NYSE: TMO) are good buying opportunities and will\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=13601\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Is Illumina Stock A Better Pick Over TMO? | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"We believe Illumina stock (NASDAQ NDAQ : ILMN) and its industry peer Thermo Fisher Scientific stock (NYSE: TMO) are good buying opportunities and will\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=13601\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-25T13:01:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-25T13:01:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/05\/1685019666_0x0.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=13601#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=13601\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"Is Illumina Stock A Better Pick Over TMO?\",\"datePublished\":\"2023-05-25T13:01:06+00:00\",\"dateModified\":\"2023-05-25T13:01:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=13601\"},\"wordCount\":1057,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"Markets\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=13601#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=13601\",\"url\":\"https:\/\/ifintechworld.com\/?p=13601\",\"name\":\"Is Illumina Stock A Better Pick Over TMO? | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-05-25T13:01:06+00:00\",\"dateModified\":\"2023-05-25T13:01:07+00:00\",\"description\":\"We believe Illumina stock (NASDAQ NDAQ : ILMN) and its industry peer Thermo Fisher Scientific stock (NYSE: TMO) are good buying opportunities and will\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=13601#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=13601\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=13601#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Is Illumina Stock A Better Pick Over TMO?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Is Illumina Stock A Better Pick Over TMO? | iFintechWorld","description":"We believe Illumina stock (NASDAQ NDAQ : ILMN) and its industry peer Thermo Fisher Scientific stock (NYSE: TMO) are good buying opportunities and will","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=13601","og_locale":"en_US","og_type":"article","og_title":"Is Illumina Stock A Better Pick Over TMO? | iFintechWorld","og_description":"We believe Illumina stock (NASDAQ NDAQ : ILMN) and its industry peer Thermo Fisher Scientific stock (NYSE: TMO) are good buying opportunities and will","og_url":"https:\/\/ifintechworld.com\/?p=13601","og_site_name":"iFintechWorld","article_published_time":"2023-05-25T13:01:06+00:00","article_modified_time":"2023-05-25T13:01:07+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/05\/1685019666_0x0.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=13601#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=13601"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"Is Illumina Stock A Better Pick Over TMO?","datePublished":"2023-05-25T13:01:06+00:00","dateModified":"2023-05-25T13:01:07+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=13601"},"wordCount":1057,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"articleSection":["Markets"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=13601#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=13601","url":"https:\/\/ifintechworld.com\/?p=13601","name":"Is Illumina Stock A Better Pick Over TMO? | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-05-25T13:01:06+00:00","dateModified":"2023-05-25T13:01:07+00:00","description":"We believe Illumina stock (NASDAQ NDAQ : ILMN) and its industry peer Thermo Fisher Scientific stock (NYSE: TMO) are good buying opportunities and will","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=13601#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=13601"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=13601#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"Is Illumina Stock A Better Pick Over TMO?"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/13601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13601"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/13601\/revisions"}],"predecessor-version":[{"id":13603,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/13601\/revisions\/13603"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/13602"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}